NIT-Based NAFLD Identification –
Understanding the New AGA Clinical Care Pathway

07/06/2022

Tuesday, June 7^th
from 12PM to 1PM

In this webinar, Dr. Harrison will review the new AGA Clinical Care Pathway for NIT-based risk stratification of patients with NAFLD risk factors. The presentation will include guidance on how to determine which risk-factor patients will benefit from testing, the NIT-based FIB-4 + LSM by VCTE™ test sequence and risk-stratified disease management guidance.

>> Watch Replay <<

Dr. Stephen Harisson

M.D. Gastroenterologist and Hepatologist, Medical Director of Pinnacle Clinical Research, United States

Replay

Watch Replay

NIT-Based NAFLD Identification –Understanding the New AGA Clinical Care Pathway

Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment

Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective

AASLD 2020 Update

NIT-Based NAFLD Identification –
Understanding the New AGA Clinical Care Pathway